Total Payments
$922.02
2022 Payments
$103.19
Companies
11
Transactions
60
Medicare Patients
865
Medicare Billing
$47,515
Payment Breakdown by Category
Food & Beverage$922.02 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $922.02 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $360.24 | 26 | $0 (2021) |
| Lilly USA, LLC | $177.44 | 10 | $0 (2022) |
| Novo Nordisk Inc | $113.65 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $74.59 | 5 | $0 (2022) |
| GlaxoSmithKline, LLC. | $55.78 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $48.99 | 3 | $0 (2022) |
| Genentech USA, Inc. | $29.34 | 2 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $18.53 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $16.45 | 1 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.13 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $103.19 | 6 | Lilly USA, LLC ($20.96) |
| 2021 | $818.83 | 54 | AbbVie Inc. ($360.24) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 04/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Neuroscience | ||||||
| 03/28/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: DIABETES | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Respiratory | ||||||
| 02/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PRIMARY CARE | ||||||
| 11/18/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: DIABETES | ||||||
| 11/10/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: PRIMARY CARE | ||||||
| 10/27/2021 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Neuroscience | ||||||
| 10/05/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Diabetes | ||||||
| 09/30/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 09/13/2021 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Neuroscience | ||||||
| 08/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: DIABETES | ||||||
| 08/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Diabetes | ||||||
| 07/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Diabetes | ||||||
| 07/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: DIABETES | ||||||
| 06/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 290 | 369 | $29,802 | $12,301 |
| 2021 | 15 | 560 | 896 | $65,016 | $33,989 |
| 2020 | 1 | 15 | 17 | $1,887 | $1,225 |
Total Patients
865
Total Services
1,282
Medicare Billing
$47,515
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 134 | $18,760 | $8,679 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $3,800 | $2,104 | 55.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 22 | 24 | $2,400 | $741.01 | 30.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 67 | 91 | $2,912 | $269.43 | 9.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 55 | 69 | $690.00 | $236.32 | 34.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $240.00 | $184.38 | 76.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 20 | $1,000 | $87.54 | 8.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 124 | 266 | $35,993 | $21,412 | 59.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 33 | 33 | $6,600 | $3,698 | 56.0% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 24 | 27 | $2,700 | $1,984 | 73.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 15 | $2,860 | $1,537 | 53.7% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 20 | 24 | $1,440 | $1,086 | 75.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $1,548 | $805.46 | 52.0% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 19 | 46 | $920.00 | $761.30 | 82.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 91 | 175 | $5,600 | $522.00 | 9.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 31 | 31 | $620.00 | $480.81 | 77.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 81 | 138 | $1,380 | $480.24 | 34.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 26 | 40 | $1,200 | $345.21 | 28.8% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 14 | 15 | $1,200 | $290.94 | 24.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 38 | 40 | $2,000 | $281.68 | 14.1% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 13 | 13 | $325.00 | $214.89 | 66.1% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2021 | 19 | 21 | $630.00 | $90.12 | 14.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 17 | $1,887 | $1,225 | 64.9% |
About Christopher Steele, RN, MSN, APRN, FNP-C
Christopher Steele, RN, MSN, APRN, FNP-C is a Registered Nurse healthcare provider based in Iowa City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2016. The National Provider Identifier (NPI) number assigned to this provider is 1841649837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Steele, RN, MSN, APRN, FNP-C has received a total of $922.02 in payments from pharmaceutical and medical device companies, with $103.19 received in 2022. These payments were reported across 60 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($922.02).
As a Medicare-enrolled provider, Steele has provided services to 865 Medicare beneficiaries, totaling 1,282 services with total Medicare billing of $47,515. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Iowa City, IA
- Active Since 06/09/2016
- Last Updated 08/25/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841649837
Products in Payments
- VRAYLAR (Drug) $337.87
- EMGALITY (Drug) $110.08
- Ozempic (Drug) $97.07
- JARDIANCE (Drug) $90.84
- TRELEGY ELLIPTA (Drug) $55.78
- TRULICITY (Drug) $51.11
- UBRELVY (Drug) $35.25
- NURTEC ODT (Drug) $32.66
- BREZTRI (Drug) $31.60
- Xofluza (Drug) $29.34
- Rybelsus (Drug) $16.58
- SOLIQUA 100/33 (Biological) $16.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Iowa City
Ann Glick
Registered Nurse — Payments: $5,369
Registered Nurse $5,369
Emily Vittetoe
Registered Nurse — Payments: $690.53
Registered Nurse $690.53
Dacia Watts, Arnp, ARNP
Registered Nurse — Payments: $157.48
Registered Nurse $157.48
Kelly Marine, Pnp, PNP
Registered Nurse — Payments: $136.06
Registered Nurse $136.06
Mckenzie Arnold, Dnp, DNP
Registered Nurse — Payments: $103.28
Registered Nurse $103.28
Paul Deninger, Crna, CRNA
Registered Nurse — Payments: $40.93
Registered Nurse $40.93